Mountain View-based
Livongo Health, which develops software to help manage diabetes, has raised $44.5M in a Series C funding. The funding came from Merck Global Health Innovation Fund, Cowen Private Investments, Sapphire Ventures, Zaffre Investments (the investment arm of Blue Cross Blue Shield of Massachusetts), Wanxiang America Corporation, plus General Catalyst, Kleiner Perkins Caufield & Byers (KPCB), DFJ, and 7wire Ventures. Livongo Health is led by Glen Tullman.
posted on Tuesday, April 12, 2016
Related companies:
Livongo Health
Related stories:
> Livongo Health Gets $10M To Better Manage Diabetes
> Livongo Health Lands $52.5M More
> Vida Health Gets $18M
> Virta Health Adds $45M For Diabetes Treatment
> Glooko Gains $16.5M For Diabetes Management App
silicontap.com Home